UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.94 -0.06 (-0.08%) GOLD FUTURES
2,312.10 +1.10 (+0.05%) DOW
38,036.72 +133.43 (+0.35%) Bitcoin GBP
47,191.87 +1,652.29 (+3.63%)
Penumbra, Inc. (PEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:54PM EDT. Market open.
| Previous close | 205.29 |
| Open | 207.08 |
| Bid | 204.19 x 800 |
| Ask | 204.58 x 800 |
| Day's range | 202.90 - 207.96 |
| 52-week range | 180.93 - 348.67 |
| Volume | |
| Avg. volume | 358,419 |
| Market cap | 7.924B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 88.12 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
- Zacks
Here's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
- GuruFocus.com
Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction according to the latest SEC filings.
© 2024 Yahoo. All rights reserved.